Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
Cancer Medicine|March 24, 2022
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathyXindi Zhang, Matthew R Trendowski, Emma Wilkinson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based ChemotherapyChunkit Fung, Howard D Sesso, Annalynn M Williams, et al.BJU International|November 19, 2016
Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative studyAmishi Y Shah, Jose A Karam, Gabriel G Malouf, et al.Eclinicalmedicine|April 13, 2026
Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort studyVictoria A Sanchez, Paul C Dinh, Patrick O Monahan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset CancerM Eileen Dolan, Omar El Charif, Heather E Wheeler, et al.Journal of the American Geriatrics Society|April 30, 2019
Effects of a Home-based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving ChemotherapyKah Poh Loh, Ian R Kleckner, Po-Ju Lin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset CancerRobert D Frisina, Heather E Wheeler, Sophie D Fossa, et al.Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer SurvivorsMohammad Abu Zaid, Wambui G Gathirua-Mwangi, Chunkit Fung, et al.Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer SurvivorsMohammad Abu Zaid, Paul C Dinh, Patrick O Monahan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 5, 2018
Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional StudySarah L Kerns, Chunkit Fung, Patrick O Monahan, et al.Pageof 8